Skip to main content
OpenTrials

Clinical trial condition

Urea Cycle Disorders, Inborn

Explore clinical trials studying Urea Cycle Disorders, Inborn. Study availability and eligibility vary by location and protocol.

41 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Urea Cycle Disorders, Inborn trial results

Active, not recruiting

Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

NCT05345171

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +12 more
Locations
  • University of California Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View all 16 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Completed

A Study of AEB1102 (Pegzilarginase) in Patients With Arginase 1 Deficiency

NCT03378531

Conditions
Amino Acid Metabolism, Inborn Errors, Arginase I Deficiency, Brain Diseases, +11 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • UTSW Dallas, Texas, United States
  • The Hospital for Sick Children Toronto, Ontario, Canada
View Trial Details
Completed

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

NCT03921541

Conditions
Amino Acid Metabolism, Inborn Errors, Arginase I Deficiency, Brain Diseases, +11 more
Locations
  • Harvey Pediatrics Rogers, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 32 locations
View Trial Details
Completed

Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency

NCT06582524

Conditions
Amino Acid Metabolism, Inborn Errors, Arginase 1 Deficiency, Brain Diseases, +11 more
Locations
  • Univ. Klinik für Kinder- und Jugendheilkunde Medizinische Universität Graz, Austria
  • Unidade de Doenças Metabólicas Pediatria, Hospital Santa Maria Lisbon, Portugal
  • Bradford Royal Infirmary Duckworth Lane Bradford, United Kingdom
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details

Related conditions